Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
Study NCT ID:
NCT00314912
Status:
UNKNOWN
Last Update Posted:
2007-07-16
First Post:
2006-04-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease
Sponsor:
Bellus Health Inc. - a GSK company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CL-758017
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None